About 15 to 20 percent of breast cancers are triple-negative, but it can still be a misunderstood breast cancer subtype. Listen to this webinar, Ask the Expert: Triple-Negative Breast Cancer to get answers to your questions on this subtype, who it affects, treatment options, and side effects for early stage and metastatic breast cancer.
This webinar features speaker Foluso Olabisi Ademuyiwa (Bisi), MD, MPH, MSCI. Dr. Ademuyiwa is a breast medical oncologist and associate professor at Washington University in St. Louis.
Understanding your subtype and its treatment options will help you make the best decisions for you. Learn more about TNBC and three common myths.
About our expert
Foluso Olabisi Ademuyiwa (Bisi), MD, MPH, MSCI
Foluso Olabisi Ademuyiwa (Bisi), MD, MPH, MSCI, is an expert in the management of all types of breast cancer. She provides patient-centered care as part of a multidisciplinary breast cancer team. Dr. Ademuyiwa is actively involved in research on triple-negative breast cancer and racial disparities in breast cancer research and serves as principal investigator on multiple clinical trials.Learn more